Sharay Anti-RF IgG (CLIA)

Primary DI

06975070761912

Basic UDI-DI Code

B-06975070761912

Reference

18144001

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

No Longer On The Market

Manufacturer

C-Luminary Biotechnology Co., Ltd.

Sharay Anti-RF IgG (CLIA) is intended for the in vitro quantitative measurement of Rheumatoid Factor G (RF-IgG) in human serum and plasma as an aid in the diagnosis of rheumatoid arthritis (RA) or other related diseases in conjunction with other laboratory and clinical findings.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).